This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
Genomic Biomarker Testing
PEACE-3 Trial
PROfound Trial
PSMAfore Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
BOND-003 Cohort P
CORE-001 Study
CORE-008
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Daniel D. Joyce, MD, MS
Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Ashish Kamat, MD
Muscle-Invasive Bladder Cancer
Advanced & Metastatic Bladder Cancer (mUC)
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Testicular, Penile & Rare GU Malignances
Testicular Cancer
Functional Urology
Functional Urology
Alan J. Wein, MD, PhD (hon.)
Urologic Catheters - CAUTI Challenges
Videos
Exclusives
Conferences
Disparities: Social Determinants of Health
Exclusive Collaborations
Health Policy in Urological Diseases
Independent Medical Education
Journal Clubs
Practice Guidelines Reviews
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Functional Urology
Men's Health
Pelvic Health
Actionable Clinical Data
Bladder Cancer
NMIBC with CIS: Evidence, Practice & Emerging Research
Risk-Stratified NMIBC Management
Trials in Progress
Prostate Cancer
Localized Prostate Cancer
CLARIFY
ESCAPE
FORT
NRG-GU 0101
RTIRE
High Risk BCR HSPC
ARASTEP
Oligometastatic Prostate Cancer
METANOVA
mHSPC
ARASEC
ASPIRE
MEVPRO-3
mCRPC
ECLIPSE
LEGION-100
MEVPRO-1 & 2
PROMISE
SECuRE
Bladder Cancer
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2026
ASCO 2026
AUA 2026
APCCC 2026
PSMA and Beyond 2026
All Conferences
View All
PCF
Go
Reset
Send Date
Subject
Created Date
ID
Asc
Desc
AUA-IBCG Bladder Cancer Forum: Debating the Future of Bladder Cancer Care
Sent on 22 May 2026
Emerging Strategies in NMIBC from AUA 2026
Sent on 19 May 2026
AUA 2026 Advances in NMIBC Treatment and Risk Stratification
Sent on 17 May 2026
AUA 2026 Updates in MIBC and Advanced Urothelial Cancer
Sent on 17 May 2026
Improving Diagnosis Assessment and Implications on Recurrence in Urothelial Cancer
Sent on 24 October 2022
Highlights in Bladder and Kidney Cancer Featuring the Society of Urologic Oncology (SUO) Sessions from the American Urological Association Annual Meeting (AUA)
Sent on 19 May 2022
Featuring the IBCG Bladder Cancer Forum from the 2022 American Urological Association Annual Meeting (AUA)
Sent on 18 May 2022
Transforming the Paradigm for Low Grade UTUC
Sent on 17 May 2022
Late Breaking Abstracts in Prostate Cancer and Highlights in Localized and Advanced Disease from the American Urological Association Annual Meeting (AUA)
Sent on 17 May 2022
AUA Guidelines in Localized Prostate Cancer and Advanced Prostate Cancer Highlights from the American Urological Association Annual Meeting (AUA)
Sent on 15 May 2022
Is A Restaging TURBT Necessary in High Risk NMIBC and Plenary Highlights in Kidney Cancer from the American Urological Association Annual Meeting (AUA)
Sent on 15 May 2022
The Optimal Multidisciplinary Team in 2022 and Prostate Cancer Highlights from the American Urological Association Annual Meeting (AUA)
Sent on 14 May 2022
Plenary Presentations in GU Malignancies and Highlights from Day 1 of the 2022 American Urological Association Annual Meeting (AUA)
Sent on 13 May 2022
Looking Forward to AUA 2022 - What to Expect in Prostate, Kidney, and Bladder Cancer
Sent on 09 May 2022
Impact of Decipher Biopsy Testing on Clinical Outcomes in Localized Prostate Cancer in a Prospective Statewide Collaborative
Sent on 12 November 2021
Kidney Cancer Association’s International Kidney Cancer Symposium 2021 Meeting Highlights
Sent on 07 November 2021
AUA 2021 Prostate Cancer Late Breaking Abstract Presentations
Sent on 13 September 2021
AUA 2021 Late-Breakers and Highlights in Bladder Cancer and Upper Tract Disease
Sent on 13 September 2021
Advances in the Treatment of Prostate Cancer Across the Disease Continuum at the AUA 2021
Sent on 12 September 2021
First and Second-Line Therapy in Advanced and Metastatic Bladder Cancer - A Changing Paradigm, AUA Guidelines on Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer and More From AUA 2021
Sent on 11 September 2021
AUA 2021 - State-of-the-art Lectures and Real-World Data in Advanced Prostate Cancer Treatment
Sent on 11 September 2021
AUA 2021 Guidelines and Case-Based Discussion in the The Evolving Landscape of Advanced Prostate Cancer Treatment
Sent on 10 September 2021
American Urological Association (AUA) 2021 - Expert Written Session Summaries Begin Friday
Sent on 08 September 2021
Display #
5
10
15
20
25
30
50
100
Results 1 - 23 out of 23
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free